It is given by injection before tests are done to see if the gallbladder and pancreas are working the way they should. It is also used to help with other tests of the stomach and intestines. Given the encouraging results, researchers hope to use the data to gather a better understanding of this rare condition. They also hope their work helps other infants and children with similar medical conditions. The study is open to patients up to one month old, and there is no cost to the participant.
Confidentiality is ensured.
Both the FDA and an institutional review board are monitoring the study. Study administrators assure that all trial related materials, including the medical records of participating children, will remain confidential and will not be identified in any reported publication. No Medline abstract available. GeneSage seeks to feature IRB-approved, competitively funded programs in upcoming issues of GeneLetter. All material on this website is protected by copyright.